Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-620-4 | CAS number: 68990-67-0 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Quillaja saponaria, Rosaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- genetic toxicity in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
According to Annex XI section 1 of the REACH Regulation, the study does not need to be conducted when testing does not appear scientifically necessary. Annex XI considers the opportunity of evaluating historical human data.
As documented in the "BIOPESTICIDES REGISTRATION ACTION DOCUMENT" for Quillaja Saponaria, the U. S. Environmental Protection Agency (http://www.epa.gov/opp00001/chem_search/reg_actions/registration/decision_PC-097095_11-Sep-09.pdf) considered Quillaja Saponaria as not mutagenic and not related to any known classes of mutagens since humans are regularly exposed to Quillaja saponins via their use as an FDA-approved flavoring agent and food additive without any reported adverse effects on human health.
Chronic feeding studies have shown that Quillaja Saponaria is not carcinogenic to mice and rats even when fed up to levels of 2200 mg/kg bw. For a long time Quillaja saponaria extracts are widely used as foaming agents in beverages and emulsifiers in foods with no report of any adverse effects. In soft drinks Quillaja extracts are used at levels of 100-500 mg/kg.
Quillaja is used in cocktail mixes and as emulsifiers in foods such as baked goods, candies, frozen dairy products, gelatine, and puddings. Other saponins are widely used in commonly consumed human food, flavoring, herbs, and spices also with no report of any adverse effects.
The WHO /FAO Expert Committee on Food Additives established an ADI (Acceptable Daily Intake) for Quillaja extracts of up to 5 mg/kg (http://www.inchem.org/documents/jecfa/jecmono/v48je03.htm#4.0).
The General Standard for Food Additives (GSFA) of the Codex Alimentarius Commission lists Quillaja Saponaria as suitable for use as foaming agent in water-based flavoured drinks, including sport, energy or electrolyte drinks with a maximum use level of 500 mg/kg (Codex Alimentarius Commission, Joint/WHO Food Standards Programme, Codex Committee on Food Additives and Contaminants, Thirty-seventh Session, The Hague, The Netherlands, 25-29 April 2005, CX/FAC 05/37/9).
Quillaja Saponaria extract are generally considered as safe (GRAS) by the Food and Drug Administration (FDA) of the United States (FEMA GRAS number 2973).
Based on the existing human data and human experience with Quillaja Saponaria the substance is not mutagenic nor carcinogenic. Therefore testing for mutagenicity is scientifically unjustified.
Justification for classification or non-classification
As outlined above, no classification and subsequent labelling of Quillaja saponaria ext. for mutagenicity is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.